These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17108214)

  • 1. Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage breast cancer patients.
    Taback B; Giuliano AE; Lai R; Hansen N; Singer FR; Pantel K; Hoon DS
    Ann N Y Acad Sci; 2006 Sep; 1075():211-21. PubMed ID: 17108214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
    Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
    Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
    Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
    Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.
    Hoque MO; Feng Q; Toure P; Dem A; Critchlow CW; Hawes SE; Wood T; Jeronimo C; Rosenbaum E; Stern J; Yu M; Trink B; Kiviat NB; Sidransky D
    J Clin Oncol; 2006 Sep; 24(26):4262-9. PubMed ID: 16908936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Xu GW; Deng GR
    Ai Zheng; 2007 Jan; 26(1):44-7. PubMed ID: 17222366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications.
    Hu XC; Wong IH; Chow LW
    Oncol Rep; 2003; 10(6):1811-5. PubMed ID: 14534701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic DNA methylation marker in serum of cancer patients.
    Müller HM; Fiegl H; Widschwendter A; Widschwendter M
    Ann N Y Acad Sci; 2004 Jun; 1022():44-9. PubMed ID: 15251938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
    Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
    Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation in serum of breast cancer patients: an independent prognostic marker.
    Müller HM; Widschwendter A; Fiegl H; Ivarsson L; Goebel G; Perkmann E; Marth C; Widschwendter M
    Cancer Res; 2003 Nov; 63(22):7641-5. PubMed ID: 14633683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
    Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation identifies progression risk in bladder cancer.
    Yates DR; Rehman I; Abbod MF; Meuth M; Cross SS; Linkens DA; Hamdy FC; Catto JW
    Clin Cancer Res; 2007 Apr; 13(7):2046-53. PubMed ID: 17404085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients.
    Ibanez de Caceres I; Battagli C; Esteller M; Herman JG; Dulaimi E; Edelson MI; Bergman C; Ehya H; Eisenberg BL; Cairns P
    Cancer Res; 2004 Sep; 64(18):6476-81. PubMed ID: 15374957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer.
    Wang Y; Yu Z; Wang T; Zhang J; Hong L; Chen L
    Lung Cancer; 2007 May; 56(2):289-94. PubMed ID: 17267069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue.
    Yan PS; Venkataramu C; Ibrahim A; Liu JC; Shen RZ; Diaz NM; Centeno B; Weber F; Leu YW; Shapiro CL; Eng C; Yeatman TJ; Huang TH
    Clin Cancer Res; 2006 Nov; 12(22):6626-36. PubMed ID: 17121881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer.
    Umetani N; Mori T; Koyanagi K; Shinozaki M; Kim J; Giuliano AE; Hoon DS
    Oncogene; 2005 Jul; 24(29):4721-7. PubMed ID: 15897910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results.
    Digel W; Lübbert M
    Crit Rev Oncol Hematol; 2005 Jul; 55(1):1-11. PubMed ID: 15886007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer.
    Wascher RA; Huynh KT; Giuliano AE; Hansen NM; Singer FR; Elashoff D; Hoon DS
    Clin Cancer Res; 2003 Apr; 9(4):1427-35. PubMed ID: 12684415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.